Last reviewed · How we verify
NCT02009189
The Value of Taurolidine Lock in Long Term Parenteral Nutrition
Phase 4 trial testing 2% Taurolidine Lock in Home Parenteral Nutrition in 30 participants. Completed in 1 December 2013.
1 November 2013
Quick facts
| Lead sponsor | Stanley Dudrick's Memorial Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 1 November 2012 |
| Primary completion | 1 November 2013 |
| Estimated completion | 1 December 2013 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- 2% Taurolidine Lock — full drug profile →
- 1.35% Taurolidine — full drug profile →
Conditions studied
- Home Parenteral Nutrition — all drugs for Home Parenteral Nutrition →
- Central Venous Catheter — all drugs for Central Venous Catheter →
Sponsor
Stanley Dudrick's Memorial Hospital
Who can join
18 and older, any sex, with Home Parenteral Nutrition or Central Venous Catheter. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Number of CVC infections
Time frame: 12 months
Number of central venous catheter infections
Sponsor's own description
Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02009189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Home Parenteral Nutrition
Currently open trials in the same condition.
- NCT07422792 — Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients · NA · recruiting
- NCT06708689 — Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments · active not recruiting
Other Stanley Dudrick's Memorial Hospital trials
Trials by the same sponsor.
- NCT05069402 — Impact of Various Diets on Surgical Complications · NA · completed
- NCT05068882 — Impact of Oral Diets on Postoperative Fluid Collection · NA · unknown
- NCT04467138 — High Dose Intravenous Fish Oil Reduces Inflammation · completed
- NCT03980704 — Preoperative High Protein vs Immunodiet in Surgical Cancer Patients · Phase 4 · completed
- NCT04771832 — ERAS in Gastrointerstinal Fistulas. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02009189 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanley Dudrick's Memorial Hospital
- Last refreshed: 10 December 2013
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02009189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing